Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

Experimental and Therapeutic Medicine

Volumn 3, Issue 5, 2012, Pages 797-802

  Yamamoto, Taketsugu ^a   Oshima, Takashi ^b   Yoshihara, Kazue ^b   Nishi, Teppei ^b   Arai, Hiromasa ^b   Inui, Kenji ^b   Kaneko, Takeshi ^b   Nozawa, Akinori ^b   Adachi, Hiroyuki ^a   Rino, Yasushi ^a   Masuda, Munetaka ^a   Imada, Toshio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Insulin like growth factor 1 receptor; Matrix metalloproteinase 7; Non small cell lung cancer

Indexed keywords

MATRILYSIN; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION;

EID: 84863370802     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.493     Document Type: Article

References (20)

1. Dufourny B, Alblas J, van Teeffelen HA, et al: Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272: 31163-31171, 1997.
2. Khandwala HM, McCutcheon IE, Flyvbjerg A and Friend KE: The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244, 2000.
3. Baserga R, Hongo A, Rubini M, Prisco M and Valentinis B: The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332: F105-F126, 1997.
4. Blakesley VA, Stannard BS, Kalebic T, Helman LJ and LeRoith D: Role of the IGF-I receptor in mutagenesis and tumor promotion. J Endocrinol 152: 339-344, 1997.
5. LeRoith D and Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137, 2003.
6. Turner BC, Haffty BG, Narayanan L, et al: Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57: 3079-3083, 1997.
7. Long L, Rubin R and Brodt P: Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp Cell Res 238: 116-121, 1998.
8. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
9. Mott JD and Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558-564, 2004.
10. Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M and Kanetake H: Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 12: 6998-7003, 2006.
11. Kitoh T, Yanai H, Saitoh Y, et al: Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J Gastroenterol 39: 434-440, 2004.
12. Liu D, Nakano J, Ishikawa S, et al: Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer 58: 384-391, 2007.
13. Leinonen T, Pirinen R, Bohm J, Johansson R, Ropponen K and Kosma VM: Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis. Lung Cancer 51: 313-321, 2006.
14. Sasaki H, Yukiue H, Moiriyama S, et al: Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101: 242-247, 2001.
15. Miyamoto S, Yano K, Sugimoto S, et al: Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res 64: 665-671, 2004.
16. Adachi Y, Li R, Yamamoto H, et al: Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin. Carcinogenesis 30: 1305-1313, 2009.
17. Dziadziuszko R, Merrick DT, Witta SE, et al: Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol 28: 2174-2180, 2010.
18. Cappuzzo F, Tallini G, Finocchiaro G, et al: Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Ann Oncol 21: 562-567, 2010.
19. Ludovini V, Bellezza G, Pistola L, et al: High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann Oncol 20: 842-849, 2009.
20. Merrick DT, Dziadziuszko R and Szostakiewicz B: High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically resected non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol 25 (Suppl): 7550, 2007.